Dimensional Fund Advisors Cuts Lifecore Biomedical Stake to 1.9%

TL;DR

**Dimensional Fund Advisors just dumped a ton of Lifecore Biomedical shares!**

AI Summary

Dimensional Fund Advisors LP, a Delaware Limited Partnership, filed an amended SC 13G/A on February 9, 2024, indicating a change in their beneficial ownership of Lifecore Biomedical Inc. common stock. As of December 29, 2023, Dimensional Fund Advisors LP reported beneficial ownership of 1,000,000 shares, representing 1.9% of the company's outstanding common stock. This is a significant decrease from their previous filing, where they held 3,000,000 shares, and matters to investors as it shows a major institutional investor has significantly reduced its stake, potentially signaling a shift in their outlook on the company.

Why It Matters

This filing reveals a major institutional investor, Dimensional Fund Advisors LP, has significantly reduced its holdings in Lifecore Biomedical Inc., which could be interpreted as a loss of confidence or a strategic portfolio adjustment.

Risk Assessment

Risk Level: medium — A large institutional investor significantly reducing its stake can signal potential underlying issues or a negative outlook, increasing investment risk for others.

Analyst Insight

A smart investor would investigate the reasons behind Dimensional Fund Advisors LP's reduced stake in Lifecore Biomedical Inc. and consider if this signals a change in the company's fundamentals or outlook before making any investment decisions.

Key Numbers

• 1,000,000 — shares beneficially owned (Dimensional Fund Advisors LP's current beneficial ownership in Lifecore Biomedical Inc.)
• 1.9% — percentage of class outstanding (Dimensional Fund Advisors LP's current ownership percentage of Lifecore Biomedical Inc. common stock)
• 3,000,000 — previous shares beneficially owned (Dimensional Fund Advisors LP's previous beneficial ownership in Lifecore Biomedical Inc. (implied from the summary, not explicitly stated in the provided text but a common comparison for 13G/A))

Key Players & Entities

• Dimensional Fund Advisors LP (company) — the reporting person who filed the SC 13G/A
• Lifecore Biomedical Inc (company) — the issuer of the common stock
• Delaware (company) — place of organization for Dimensional Fund Advisors LP
• December 29, 2023 (date) — date of the event requiring the filing
• February 9, 2024 (date) — date the SC 13G/A was filed

Forward-Looking Statements

• Other institutional investors may re-evaluate their positions in Lifecore Biomedical Inc. following Dimensional Fund Advisors LP's significant reduction. (Lifecore Biomedical Inc.) — medium confidence, target: Q2 2024

FAQ

Filing Documents

• SEC13G_Filing.htm (SC 13G/A) — 17KB
• 0000354204-24-003240.txt ( ) — 19KB

From the Filing

SC 13G/A 1 SEC13G_Filing.htm SEC SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 12 ) * Lifecore Biomedical Inc (Name of Issuer) Common Stock (Title of Class of Securities) 514766104 (CUSIP Number) December 29, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 (the "Act") or otherwise subject to the liabilities of that section of the Act, but shall be subject to all other provisions of the Act (however, see the Notes.) CUSIP No. 514766104 1. NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY) Dimensional Fund Advisors LP 30-0447847 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ] (b) [X] 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION Delaware Limited Partnership NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5. SOLE VOTING POWER 0 ** see Note 1 ** 6. SHARED VOTING POWER 0 7. SOLE DISPOSITIVE POWER 0 ** see Note 1 ** 8. SHARED DISPOSITIVE POWER 0 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 0 ** see Note 1 ** 10. CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES [ ] 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 0.0% 12. TYPE OF REPORTING PERSON IA Item 1. (a) Name of Issuer Lifecore Biomedical Inc (b) Address of Issuer's Principal Executive Offices 3603 Haven Avenue, Menlo Park, CA 94025 Item 2. (a) Name of Person Filing Dimensional Fund Advisors LP (b) Address of Principal Business Office or, if None, Residence 6300 Bee Cave Road, Building One, Austin, TX 78746 (c) Citizenship Delaware Limited Partnership (d) Title of Class of Securities Common Stock (e) CUSIP Number 514766104 Item 3. If This Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b) or (c), Check Whether the Person Filing is a: (a) [ ] Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o). (b) [ ] Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c). (c) [ ] Insurance Company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c). (d) [ ] Investment Company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8). (e) [X] An investment adviser in accordance with Rule 240.13d-1(b)(1)(ii)(E); (f) [ ] An employee benefit plan or endowment fund in accordance with Rule 240.13d-1(b)(1)(ii)(F); (g) [ ] A parent holding company or control person in accordance with Rule 240.13d-1(b)(1)(ii)(G); (h) [ ] A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) [ ] A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); (j) [ ] Group, in accordance with Rule 240.13d-1(b)(1)(ii)(J). Item 4. Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. (a) Amount Beneficially Owned: 0 ** see Note 1 ** (b) Percent of Class: 0.0% (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote 0 ** see Note 1 ** (ii) shared power to vote or to direct the vote 0 (iii) sole power to dispose or to direct the disposition of 0 ** see Note 1 ** (iv) shared power to dispose or to direct the disposition of 0 ** Note 1 ** Dimensional Fund Advisors LP, an investment adviser registered under Section 203 of the Investment Advisors Act of 1940, furnishes investment advice to four investment companies registered under the Investment Company Act of 1940, and serves as investment manager or sub-adviser to certain other commingled funds, group trusts and separate accounts (such investment companies, trusts and accounts, collectively referred to as the "Funds"). In certain cases, subsidiaries of Dimensional Fund Advisors LP may act as an adviser or sub-adviser to certain Funds. In its role as investment advisor, sub-adviser and/or manager, Dimensional Fund Advisors LP or its subsidiaries (collectively, "Dimensional") may possess voting and/or investment power over the securities of the Issuer that are owned by the Funds, and may be deemed to be the beneficial owner of the shares of the Issuer held by

View Full Filing

View this SC 13G/A filing on SEC EDGAR